nlvpartners http://www.nlvpartners.com Funding the healthcare revolution. Fri, 17 Nov 2017 18:59:22 +0000 en-US hourly 1 https://wordpress.org/?v=4.8.3 News | October 3, 2017 http://www.nlvpartners.com/news-october-3-2017/ Fri, 17 Nov 2017 17:46:22 +0000 http://www.nlvpartners.com/?p=5955 Ultragenyx Enters into Definitive Agreement to Acquire Dimension for $6.00 Per Share in Cash in a Transaction Valued at Approximately $151 Million Based on Currently Outstanding Shares Combined Company will be Strongly Positioned to Bring Needed New Therapies to Market  NOVATO, Calif., and CAMBRIDGE, Mass., Oct. 03, 2017 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) […]

The post News | October 3, 2017 appeared first on nlvpartners.

]]>
News | November 15, 2017 http://www.nlvpartners.com/news-november-15-2017-2/ Fri, 17 Nov 2017 17:40:06 +0000 http://www.nlvpartners.com/?p=5952 Arvinas Expands Strategic License Agreement with Genentech Expansion of 2015 agreement brings total deal value to potentially exceed $650 million NEW HAVEN, Conn., November 15, 2017 – Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, today announced it has expanded its ongoing license agreement with Genentech, a […]

The post News | November 15, 2017 appeared first on nlvpartners.

]]>
News | November 15, 2017 http://www.nlvpartners.com/news-november-15-2017/ Fri, 17 Nov 2017 17:28:40 +0000 http://www.nlvpartners.com/?p=5949 Jefferson Health Selects Kyruus’ Solutions to Support Its Expansion and Enhance Patient Access Growing Health System to Build Comprehensive Provider Directory and Optimize Patient-Provider Matching Boston, MA – Kyruus, a leader in provider search and scheduling solutions for health systems, today announced that Jefferson Health, a leading academic health system in Pennsylvania and New Jersey, will […]

The post News | November 15, 2017 appeared first on nlvpartners.

]]>
News | November 09, 2017 http://www.nlvpartners.com/news-november-09-2017/ Mon, 13 Nov 2017 19:21:46 +0000 http://www.nlvpartners.com/?p=5919 SANOFI, PRINCIPIA AGREE TO DEVELOP MULTIPLE SCLEROSIS DRUG CANDIDATE Clinical-stage oral drug candidate (PRN2246) with the potential to treat multiple sclerosis Principia to receive $40 million upfront payment, future milestone payments could total $765 million 
Paris, France and South San Francisco, Calif – November 9, 2017 – Sanofi will develop Principia Biopharma Inc.’s experimental oral treatment that […]

The post News | November 09, 2017 appeared first on nlvpartners.

]]>
News | October 9, 2017 http://www.nlvpartners.com/news-october-9-2017/ Fri, 20 Oct 2017 20:38:53 +0000 http://www.nlvpartners.com/?p=5883 Neuronetics Named 2017 Health Care Innovator by Philadelphia Business Journal Recognized for company’s breakthrough non-drug depression treatment, NeuroStar® Advanced Therapy Malvern, Pa., October 9, 2017 – Neuronetics, Inc., a privately held medical device company widely recognized as the market-leader in transcranial magnetic stimulation (TMS) with its NeuroStar Advanced Therapy for depression, has been named a […]

The post News | October 9, 2017 appeared first on nlvpartners.

]]>
News | October 11, 2017 http://www.nlvpartners.com/news-october-11-2017/ Fri, 20 Oct 2017 20:27:22 +0000 http://www.nlvpartners.com/?p=5880 NeuroStar® Advanced Therapy Approved as a Life-Changing Depression Treatment to Help Conquer Depression in Japan Proven, breakthrough non-drug treatment provides safe and effective option to the country’s critical public health issue Proven, breakthrough non-drug treatment provides safe and effective option to the country’s critical public health issue News provided by NeuroStar Advanced Therapy MALVERN, Pa., […]

The post News | October 11, 2017 appeared first on nlvpartners.

]]>
News | October 16, 2017 http://www.nlvpartners.com/news-october-16-2017/ Fri, 20 Oct 2017 18:20:10 +0000 http://www.nlvpartners.com/?p=5876 Neuronetics, Inc. Partners with Teijin Pharma Limited, a Leading Healthcare Company in Japan, to Distribute NeuroStar Advanced Therapy Partnership expands access to transformative, non-drug depression treatment to millions MALVERN, Pa., Oct. 16, 2017 /PRNewswire/ — Neuronetics, Inc., a privately held medical device company widely recognized as the market-leader in transcranial magnetic stimulation (TMS), announced today it […]

The post News | October 16, 2017 appeared first on nlvpartners.

]]>
News | September 26, 2017 http://www.nlvpartners.com/news-september-26-2017/ Fri, 20 Oct 2017 18:14:40 +0000 http://www.nlvpartners.com/?p=5874 Kyruus ProviderMatch™ to Help Emory Healthcare Raise the Bar on Patient Access by Kyruus, on Sep 26, 2017 8:20:23 AM Leading Health System Will Implement Multi-Channel Patient Access Solution to Enhance the Patient Experience and Boost Operational Efficiency Boston, MA – Kyruus, a leader in provider search and scheduling solutions for health systems, today announced that Emory […]

The post News | September 26, 2017 appeared first on nlvpartners.

]]>
News | September 15, 2017 http://www.nlvpartners.com/news-september-15-2017/ Fri, 20 Oct 2017 18:10:05 +0000 http://www.nlvpartners.com/?p=5872 Alysha Fluno Joins Truveris as Chief Pharmacy Officer Alysha Fluno has joined Truveris as Chief Pharmacy Officer where she will be involved in developing thought leadership programs and in strategic account management. Fluno is an experienced clinical professional with a diverse background in the pharmacy industry. Before joining Truveris, she served as a pharmacist and […]

The post News | September 15, 2017 appeared first on nlvpartners.

]]>
News | October 18, 2017 http://www.nlvpartners.com/news-october-18-2017/ Fri, 20 Oct 2017 18:07:10 +0000 http://www.nlvpartners.com/?p=5870 AbbVie and Harpoon Therapeutics Announce Immuno-Oncology Research Collaboration NORTH CHICAGO, Ill. and SOUTH SAN FRANCISCO, Calif. – Oct. 18, 2017 – AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Harpoon Therapeutics, a biotechnology company developing novel T-cell recruiting biologic therapies, announced today that they have entered an immuno-oncology research collaboration. The goal of the collaboration […]

The post News | October 18, 2017 appeared first on nlvpartners.

]]>